NASDAQ OMX

London Court of Appeal Validates IPCom's Mobile Telecoms Patent Critical to the UMTS Standard

Dela

IPCom GmBH & Co. KG / London Court of Appeal Validates IPCom's Mobile Telecoms Patent Critical to the UMTS Standard . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement.

Mobile Telecoms Patent is essential to UMTS networks

MUNICH, Germany, Jan. 09, 2018 (GLOBE NEWSWIRE) -- IPCom, a leading patent licensing entity with a global portfolio of mobile telecommunications patents, today announced that, earlier in 2017, the London Court of Appeal confirmed both the validity and infringement of IPCom's mobile telecoms European Patent (EP 1 841 268) (the "'100A") in its decision against the leading global handset vendor, HTC. The confirmation by the Court of Appeal of the validity of this critical patent and of HTC's infringement demonstrates the value and quality of this technology to mobile telecommunications companies.  In the event that the parties are unable to reach a settlement on the terms of a fair, reasonable and non-discriminatory ("FRAND") license, the parties will move next to the damages inquiry phase of the action.  In addition to the 100A action in the United Kingdom, as part of its ongoing effort to protect its intellectual property rights, IPCom recently filed a lawsuit against HTC in Germany for infringement of two additional IPCom patents. 

"We're pleased the Court found, after significant investigation and appeals, that the 100A is valid and essential to the UMTS standard," said Bernhard Frohwitter, managing director and co-founder of IPCom. "At long last, this paves the way for the industry as a whole to move forward with clear direction established by the court system. IPCom, with a portfolio of over 1,150 relevant or essential patents, stands ready to engage diligently with all manufacturers and service providers in the mobile industry."

Achieving this confirmation of validity and infringement was long and hard-fought but the decision by the Court of Appeal establishes that the 100A is standard-essential and mandatory to the UMTS standard. This particular patent is related to controlling how UMTS mobile telephones gain initial access to the network. As a result, any entity developing networks, handsets, or equipment for today's mobile networks should be engaging with IPCom regarding this critical element, as well as the hundreds of other relevant mobile technology patents within the firm's portfolio.

IPCom continues to engage with any industry participants who wish to take licenses on FRAND conditions as set forth by the European Commission and relayed to the European Telecommunications Standards Institute (ETSI). IPCom has a policy of offering all market participants implementing standards-compliant products and services FRAND licences and has been diligently doing so for many years. The confirmation of the 100A's validity and infringement by implementation of the UMTS standard reinforces the fact that UMTS implementors, if not already licensed, should be taking steps to negotiate with IPCom concerning its essential patent portfolio.

Companies manufacturing or selling mobile devices or offering services compliant with 2G (GMS), 2.5G (GPRS), 3G (UMTS) and 4G (LTE) should, therefore, contact IPCom to request a FRAND license agreement.  To request a license, please send your company name and contact information to ross@ipcom-munich.com

About IPCom
IPCom is a Patent Licensing Entity founded in 2007 to establish a link between patent developers and patent users. Its core business is the global licensing of patents from its own portfolio to manufacturers in the industry. Bosch originally developed IPCom's patents. The current patent portfolio encompasses approximately 1150 patents in the field of mobile communications, registered in Europe, the US and Asia. Among these are a number of patents that are declared standard-essential for the key mobile communications standards of 2G (GMS), 2.5G (GPRS), 3G (UMTS) and 4G (LTE).

For more information: 
Jay Nichols
Nichols Communications
jay@nicholscomm.com
Tel: +1 408-772-1551 




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: IPCom GmBH & Co. KG via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från NASDAQ OMX

Immunicum AB (publ) Announces Appointment of Pawel Kalinski and Inge Marie Svane to Scientific Advisory Board17.9.2018 08:00Pressmeddelande

Press Release 17 September 2018 Immunicum AB (publ) Announces Appointment of Pawel Kalinski and Inge Marie Svane to Scientific Advisory Board Immunicum AB (publ; IMMU.ST) announced today the appointment of leading oncology experts to its Scientific Advisory Board with the addition of Pawel Kalinski, MD, PhD, Vice Chair for Translational Research within the Department of Medicine at Roswell Park Comprehensive Cancer Center, and Inge Marie Svane, MD, PhD, Professor, Head of the Clinical Cancer Research programme, Faculty of Health Sciences, University of Copenhagen, Director, Centre for Cancer Immunotherapy (CCIT), and consultant in Oncology, Herlev University Hospital. Both Scientific Advisory Board members will serve as a strategic resource to Immunicum as the company continues to advance the clinical development of its lead product, ilixadencel. "We are honored to have such highly specialized experts in the field of immuno-oncology and cell therapy join our Scientific Advisory Board a

Immunicum AB (publ) meddelar att Pawel Kalinski och Inge Marie Svane har valts in i det vetenskapliga rådet17.9.2018 08:00Pressmeddelande

Pressmeddelande 17 september 2018 Immunicum AB (publ) meddelar att Pawel Kalinski och Inge Marie Svane har valts in i det vetenskapliga rådet Immunicum AB (publ; IMMU.ST) meddelade i dag att två ledande immun-onkologiska experter har valts in i bolagets vetenskapliga råd för att fungera som strategiska resurser för Immunicum under bolagets fortsatta kliniska utveckling av sin ledande produkt, ilixadencel. Pawel Kalinski, MD, PhD, vice ordförande för translationell forskning vid den medicinska institutionen vid Roswell Park Comprehensive Cancer Center, och Inge Marie Svane, MD, PhD, professor, chef för det kliniska cancerforskningsprogrammet på medicinska fakulteten vid Köpenhamns universitet, chef för Center för cancerimmunterapi (CCIT) samt överläkare inom onkologi, Herlevs universitetssjukhus har valts in i rådet. - Vi är hedrade att ha experter med specialistkompetens inom området immunonkologi och cellterapi i vårt vetenskapliga råd, vilka kan erbjuda ytterligare vägledning när det

Hoylu AB: HOYLU HIRES NEW CTO, SATOSHI NAKAJIMA AND ANNOUNCES EXPANSION INTO JAPAN14.9.2018 08:30Pressmeddelande

Malmo, Sweden, September 14, 2018 - Hoylu, a leading enterprise collaboration company, announced today Satoshi Nakajima will join Hoylu in the newly created position, as Chief Technology Officer and President of Hoylu Japan. Nakajima will guide the strategic technology direction and innovation of Hoylu while also leading the new Hoylu office in Tokyo, Japan. "Satoshi is a visionary and world-class technologist who has substantial experience in delivering world class innovations. He is joining the Company as we are extending our reach and expanding into Japan," said Stein Revelsby, CEO. "Satoshi's extensive experience in strategy and delivering technology that support a great user experience will make an immediate impact on the company." Nakajima will serve as President of Hoylu Japan and will report to Stein Revelsby. His leadership will strengthen customer relations and help develop new business among emerging and established Japanese companies while strengthening the global position

Hoylu AB: HOYLU ANSTÄLLER SATOSHI NAKAJIMA SOM NY CTO OCH EXPANDERAR TILL JAPAN14.9.2018 08:30Pressmeddelande

Malmö, Sverige, 14 september 2018 - Hoylu, ett ledande företag inom samarbetsmjukvara för företagsmarknaden annonserar idag att Satoshi Nakajima tar anställning som CTO (Chief Technology Officer) och President för Hoylu Japan. Nakajima kommer styra den strategiska inriktningen för företagets produkter och leda innovationsarbetet. Han kommer också leda Hoylus nyöppnade kontor i Tokyo, Japan. Satoshi är en visionär teknologiexpert som har stor erfarenhet av att skapa innovativa lösningar. Han kommer till Hoylu samtidigt som vi utökar marknaden till att även täcka in Japan säger Stein Revelsby, VD. "Satoshis långa och gedigna erfarenhet i strategiska frågor och tekniska lösningar med fokus på användarupplevelse kommer få stor betydelse för oss." Nakajima kommer även att bli President för Hoylu Japan och kommer rapportera till Stein Revelsby. Hans ledarskap kommer stärka existerande kundrelationer och utveckla nya affärer på den japanska marknaden och samtidigt bidra till att flytta fram p

LeoVegas AB: LeoVentures invests in esports betting - Pixel.bet13.9.2018 08:45Pressmeddelande

The LeoVegas Group, through its wholly owned investment company LeoVentures Ltd, has acquired 51% of the shares in Pixel Holding Group Ltd, which runs the esports betting operator Pixel.bet. The investment amounts to EUR 1.5 million for 51 percent of the company and is made through a new issue. Pixel.bet's vision is to create the greatest gaming experience in betting on esports www.pixel.bet "Esports is an international and fast-growing area that engages millions of viewers and players every month. With this investment in Pixel.bet we as a Group will gain unique insight into a new and fast-growing segment," comments Gustaf Hagman, LeoVegas' Group CEO and co-founder of LeoVegas Mobile Gaming Group. "In Pixel.bet we have found a passionate team of entrepreneurs who come from the esports community. With its strong technology and mobile-first gaming experience, Pixel.bet is a perfect match for the LeoVegas Mobile Gaming Group. Together we will drive development for the absolute premier exp

LeoVegas AB: LeoVentures investerar i esport betting - Pixel.bet13.9.2018 08:45Pressmeddelande

LeoVegas-koncernen har, genom sitt helägda investmentbolag LeoVentures Ltd förvärvat Pixel Holding Group Ltd, som driver esport betting operatören pixel.bet. Investeringen uppgår till 1,5 miljoner euro för 51 procent av bolaget och görs genom en nyemission. Pixel.bets vision är att skapa den främsta spelupplevelsen inom betting på esport www.pixel.bet "Esport är ett internationellt och snabbt växande område som engagerar miljontals tittare och utövare varje månad. Med investeringen i Pixel.bet får vi som koncern en unik inblick i ett nytt och snabbt växande segment.", säger Gustaf Hagman, Group CEO och co-founder av LeoVegas Mobile Gaming Group. "I Pixel.bet fann vi ett passionerat entreprenörsteam som verkligen kommer inifrån esport communityn. Med en riktigt bra teknik och spelupplevelse utvecklad mobile-first är det en perfekt match med LeoVegas Mobile Gaming Group. Tillsammans ska vi driva utveckling för den absolut främsta upplevelsen inom esport betting.", säger Robin Ramm-Ericso

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum